Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

A feasibility cluster randomised controlled trial of a paramedic-administered breathlessness management intervention for acute-on-chronic breathlessness (BREATHE)

Matthew Northgraves, Judith Cohen, Victoria Allgar, David Currow, Simon Hart, Kelly Hird, Andrew Hodge, Miriam Johnson, Suzanne Mason, Flavia Swan, Ann Hutchinson
ERJ Open Research 2021 7: 00955-2020; DOI: 10.1183/23120541.00955-2020
Matthew Northgraves
1Hull Health Trials Unit, University of Hull, Hull, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew Northgraves
  • For correspondence: matthew.northgraves@hyms.ac.uk
Judith Cohen
1Hull Health Trials Unit, University of Hull, Hull, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victoria Allgar
2Hull York Medical School / Health Sciences, University of York, York, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Currow
3Faculty of Health, University of Technology Sydney, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Hart
4Respiratory Research Group, Hull York Medical School, Cottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Simon Hart
Kelly Hird
5Yorkshire Ambulance Service NHS Trust, Wakefield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Hodge
5Yorkshire Ambulance Service NHS Trust, Wakefield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miriam Johnson
6Wolfson Palliative Care Research Group, Hull York Medical School, Hull, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzanne Mason
7CURE group, School of Health and Related Research, University of Sheffield, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Flavia Swan
6Wolfson Palliative Care Research Group, Hull York Medical School, Hull, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Hutchinson
6Wolfson Palliative Care Research Group, Hull York Medical School, Hull, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    BREATHE Study flowchart.

Tables

  • Figures
  • TABLE 1

    Schedule of events for patient-participants

    VisitCall-out (baseline)48 hDay 14Day 30Month 6
    Day02 (±0 days)14 (±7 days)30 (±7 days)183 (±7 days)
    Procedure/assessment
     Inclusion/exclusion criteria assessmentx
     Call-out informed consentx
     NRS 0–10 breathlessness every 2 min (patient)x
     Routinely collected paramedic datax
     Demographic measures (patient and carer)x
     Index ambulance call-out outcomex
     Further call-outs in 48 h after index call-outx
     Follow-up informed consentx
     Interview (patient and carer)x
     Health service utilisation questionnaire (patient)xxx
     SF-36 (patient)xxx
     CRQ-Dyspnoea Questionnaire (patient)xxx

    NRS: numerical rating scale; SF-36: Short Form 36; CRQ: Chronic Respiratory Questionnaire.

    • TABLE 2

      BREATHE intervention and usual care

      InterventionExamples of techniquesSupporting evidence
      Be reassured#Reassure patient and carer; a reassuring and expert presence is sometimes sufficient to start “unwinding” escalating breathlessness[25, 26]
      Resting positionCheck posture; find the most comfortable and efficient position to maximise ventilation[25, 27, 28]
      Exercises (breathing)Use to slow breathing rate and encourage breathing out to prevent air trapping (e.g. pursed lip or “breathing rectangle”); pursed lip breathing also provides increased end-expiratory pressure[25–29]
      AirflowUse hand-held fan; airflow across lower face/nasal passages can reduce breathlessness and recovery time[30–32]
      Time#“Take it easy, nice and slow”#[25–27]
      Help with fears and worries#Simple techniques to manage panic and fear#[25–27]
      Education of patient and carerInformation booklet and laminated card with BREATHE intervention[25–28]
      Intervention points:
      •  a) the techniques are often simultaneously delivered and tailored to the individual

      •  b) #: denotes anxiety-focused management

      •  c) The laminated BREATHE card, the information booklet and hand-held fan will be packaged in a “BREATHE folder” for paramedics to take into the house of a breathless patient.

      Usual careJRCALC Guidelines [21]
       Immediate clinical assessmentHistory, baseline vital signs and targeted examination (e.g. chest auscultation, peak flow, 12-lead ECG)
       ReassuranceReassurance is a mainstay of high-quality patient care
       OxygenTime critical feature: oxygen saturations of <94% or less for those patients without chronic lung diseases
      Target range oxygen saturation in patients with chronic lung diseases: 88–92%
      If SpO2 >92%, oxygen would not be administered
       NebuliserDepending on the initial assessment, the paramedic may ask the patient to use their own inhalers, or proceed to nebulisation

      JRCALC: Joint Royal Colleges Ambulance Liaison Committee; ECG: electrocardiogram; SpO2: oxygen saturation.

      • TABLE 3

        Stop–go criteria

        Recruitment
        GreenIf ≥80% of target patient-participants are recruited to target
        AmberBetween ≥60% and <80% patient-participants recruited and remediable barriers identified and addressed in main trial protocol
        Red<60% of the estimated sample size for a full trial cannot be completed by 24 months
        Intervention adherence#
        Green≥75%
        Amber≥50 and <75%; possible if further modelled for the main trial protocol by addressing remediable factors
        Red<50%; it would be concluded that the intervention cannot be sufficiently implemented in practice and a main trial not possible
        • Green: main trial feasible; amber: feasible with remediable factors addressed; red: main trial not feasible. #: eligible patient-participants attended by a paramedic allocated to and trained in the intervention received the intervention.

      PreviousNext
      Back to top
      Vol 7 Issue 1 Table of Contents
      ERJ Open Research: 7 (1)
      • Table of Contents
      • Index by author
      Email

      Thank you for your interest in spreading the word on European Respiratory Society .

      NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

      Enter multiple addresses on separate lines or separate them with commas.
      A feasibility cluster randomised controlled trial of a paramedic-administered breathlessness management intervention for acute-on-chronic breathlessness (BREATHE)
      (Your Name) has sent you a message from European Respiratory Society
      (Your Name) thought you would like to see the European Respiratory Society web site.
      CAPTCHA
      This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
      Print
      Citation Tools
      A feasibility cluster randomised controlled trial of a paramedic-administered breathlessness management intervention for acute-on-chronic breathlessness (BREATHE)
      Matthew Northgraves, Judith Cohen, Victoria Allgar, David Currow, Simon Hart, Kelly Hird, Andrew Hodge, Miriam Johnson, Suzanne Mason, Flavia Swan, Ann Hutchinson
      ERJ Open Research Jan 2021, 7 (1) 00955-2020; DOI: 10.1183/23120541.00955-2020

      Citation Manager Formats

      • BibTeX
      • Bookends
      • EasyBib
      • EndNote (tagged)
      • EndNote 8 (xml)
      • Medlars
      • Mendeley
      • Papers
      • RefWorks Tagged
      • Ref Manager
      • RIS
      • Zotero
      Share
      A feasibility cluster randomised controlled trial of a paramedic-administered breathlessness management intervention for acute-on-chronic breathlessness (BREATHE)
      Matthew Northgraves, Judith Cohen, Victoria Allgar, David Currow, Simon Hart, Kelly Hird, Andrew Hodge, Miriam Johnson, Suzanne Mason, Flavia Swan, Ann Hutchinson
      ERJ Open Research Jan 2021, 7 (1) 00955-2020; DOI: 10.1183/23120541.00955-2020
      del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
      Full Text (PDF)

      Jump To

      • Article
        • Abstract
        • Abstract
        • Introduction
        • Study aim and objectives
        • Methods and analysis
        • Ethics and dissemination
        • Discussion
        • Acknowledgements
        • Footnotes
        • References
      • Figures & Data
      • Info & Metrics
      • PDF
      • Tweet Widget
      • Facebook Like
      • Google Plus One

      More in this TOC Section

      • Eradication of early MRSA infection in cystic fibrosis
      • AROMA
      • The disease-specific clinical trial network for PCD
      Show more Study protocols

      Related Articles

      Navigate

      • Home
      • Current issue
      • Archive

      About ERJ Open Research

      • Editorial board
      • Journal information
      • Press
      • Permissions and reprints
      • Advertising

      The European Respiratory Society

      • Society home
      • myERS
      • Privacy policy
      • Accessibility

      ERS publications

      • European Respiratory Journal
      • ERJ Open Research
      • European Respiratory Review
      • Breathe
      • ERS books online
      • ERS Bookshop

      Help

      • Feedback

      For authors

      • Instructions for authors
      • Publication ethics and malpractice
      • Submit a manuscript

      For readers

      • Alerts
      • Subjects
      • RSS

      Subscriptions

      • Accessing the ERS publications

      Contact us

      European Respiratory Society
      442 Glossop Road
      Sheffield S10 2PX
      United Kingdom
      Tel: +44 114 2672860
      Email: journals@ersnet.org

      ISSN

      Online ISSN: 2312-0541

      Copyright © 2023 by the European Respiratory Society